Artemether-lumefantrine versus chloroquine for the treatment of uncomplicated Plasmodium knowlesi malaria (CAN KNOW): an open-label randomized controlled trial
| Autor: | Grigg, MJ, William, T, Barber, BE, Rajahram, GS, Menon, J, Schimann, E, Wilkes, CS, Patel, K, Chandna, A, Price, RN, Yeo, TW, Anstey, NM |
|---|---|
| Jazyk: | angličtina |
| Předmět: | |
| Zdroj: | Clinical Infectious Diseases. 66(2) |
| ISSN: | 1537-6591 1058-4838 |
| Popis: | Plasmodium knowlesi is reported increasingly across Southeast Asia, and is the commonest cause of malaria in Malaysia. No randomized trials have assessed comparative efficacy of artemether-lumefantrine (AL) for knowlesi malaria.A randomized-controlled trial was conducted in 3 district hospitals in Sabah, Malaysia to compare the efficacy of AL against chloroquine (CQ) for uncomplicated knowlesi malaria. Participants were included if >10kg, parasitemia |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|